Temozolomide In Acute Myeloid Leukemia: A MGMT Promoter Methylation Status-Based Treatment Stratification

被引：0
|
作者：
Medeiros, Bruno C.
Kohrt, Holbrook E.
Rajwanshi, Richa
Gotlib, Jason [1 ]
Coutre, Steven
Liedtke, Michaela [1 ]
Berube, Caroline
Zhang, Melody [1 ]
Arber, Daniel A. [2 ]
Zehnder, James L. [3 ]
机构：
[1] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA
[2] Stanford Univ, Med Ctr, Dept Clin Lab, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1357 / 1358
页数：2
相关论文
共 50 条
  • [31] Comorbidity and disease status-based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation
    Sorror, Mohamed L.
    Sandmaier, Brenda M.
    Storer, Barry E.
    Maris, Michael B.
    Baron, Frederic
    Maloney, David G.
    Scott, Bart L.
    Deeg, H. Joachim
    Appelbaum, Frederick R.
    Storb, Rainer
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (27) : 4246 - 4254
  • [32] Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status
    Wu, Qiong
    Berglund, Anders E.
    Macaulay, Robert J.
    Etame, Arnold B.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (20)
  • [33] Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients
    Kavouridis, Vasileios K.
    Ligon, Keith L.
    Wen, Patrick Y.
    Iorgulescu, J. Bryan
    JOURNAL OF NEURO-ONCOLOGY, 2022, 158 (01) : 111 - 116
  • [34] Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients
    Vasileios K. Kavouridis
    Keith L. Ligon
    Patrick Y. Wen
    J. Bryan Iorgulescu
    Journal of Neuro-Oncology, 2022, 158 : 111 - 116
  • [35] Utilization of MGMT Promoter Methylation Status to Guide Treatment in Elderly Patients With Glioblastoma
    Chu, Tiffany
    Wang, Ting
    Silberstein, Peter
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (06)
  • [36] MGMT promoter methylation status: time for a frank discussion
    Niamh Coleman
    Leslie Bridges
    Frank Saran
    Journal of Neuro-Oncology, 2017, 133 : 667 - 668
  • [37] Assessment of MGMT promoter methylation status in pleomorphic xanthoastrocytoma
    Gianluca Marucci
    Luca Morandi
    Journal of Neuro-Oncology, 2011, 105 : 397 - 400
  • [38] MGMT promoter methylation status and expression in human glioblastoma
    Rodriguez, FJ
    Thibodeau, SN
    Jenkins, RB
    Schowalter, KV
    O'Neill, BP
    James, CD
    Giannini, C
    MODERN PATHOLOGY, 2006, 19 : 287A - 287A
  • [39] The Significance of MGMT Promoter Methylation Status in Diffuse Glioma
    Jovanovic, Nikola
    Lazarevic, Milica
    Cvetkovic, Vladimir J.
    Nikolov, Vesna
    Peric, Jelena Kostic
    Ugrin, Milena
    Pavlovic, Sonja
    Mitrovic, Tatjana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [40] MGMT promoter methylation status: time for a frank discussion
    Coleman, Niamh
    Bridges, Leslie
    Saran, Frank
    JOURNAL OF NEURO-ONCOLOGY, 2017, 133 (03) : 667 - 668
12345